These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 22012983)

  • 1. Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice.
    Yatsuga S; Suomalainen A
    Hum Mol Genet; 2012 Feb; 21(3):526-35. PubMed ID: 22012983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketogenic diet slows down mitochondrial myopathy progression in mice.
    Ahola-Erkkilä S; Carroll CJ; Peltola-Mjösund K; Tulkki V; Mattila I; Seppänen-Laakso T; Oresic M; Tyynismaa H; Suomalainen A
    Hum Mol Genet; 2010 May; 19(10):1974-84. PubMed ID: 20167576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial myopathy induces a starvation-like response.
    Tyynismaa H; Carroll CJ; Raimundo N; Ahola-Erkkilä S; Wenz T; Ruhanen H; Guse K; Hemminki A; Peltola-Mjøsund KE; Tulkki V; Oresic M; Moraes CT; Pietiläinen K; Hovatta I; Suomalainen A
    Hum Mol Genet; 2010 Oct; 19(20):3948-58. PubMed ID: 20656789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype.
    Wenz T; Diaz F; Spiegelman BM; Moraes CT
    Cell Metab; 2008 Sep; 8(3):249-56. PubMed ID: 18762025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components.
    Bastin J; Aubey F; Rötig A; Munnich A; Djouadi F
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1433-41. PubMed ID: 18211970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice.
    Tyynismaa H; Mjosund KP; Wanrooij S; Lappalainen I; Ylikallio E; Jalanko A; Spelbrink JN; Paetau A; Suomalainen A
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17687-92. PubMed ID: 16301523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo correction of COX deficiency by activation of the AMPK/PGC-1α axis.
    Viscomi C; Bottani E; Civiletto G; Cerutti R; Moggio M; Fagiolari G; Schon EA; Lamperti C; Zeviani M
    Cell Metab; 2011 Jul; 14(1):80-90. PubMed ID: 21723506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease.
    Johri A; Calingasan NY; Hennessey TM; Sharma A; Yang L; Wille E; Chandra A; Beal MF
    Hum Mol Genet; 2012 Mar; 21(5):1124-37. PubMed ID: 22095692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxytyrosol promotes mitochondrial biogenesis and mitochondrial function in 3T3-L1 adipocytes.
    Hao J; Shen W; Yu G; Jia H; Li X; Feng Z; Wang Y; Weber P; Wertz K; Sharman E; Liu J
    J Nutr Biochem; 2010 Jul; 21(7):634-44. PubMed ID: 19576748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endurance exercise is protective for mice with mitochondrial myopathy.
    Wenz T; Diaz F; Hernandez D; Moraes CT
    J Appl Physiol (1985); 2009 May; 106(5):1712-9. PubMed ID: 19286571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice.
    Amengual J; Ribot J; Bonet ML; Palou A
    Obesity (Silver Spring); 2008 Mar; 16(3):585-91. PubMed ID: 18239600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice lacking COX10 in skeletal muscle recapitulate the phenotype of progressive mitochondrial myopathies associated with cytochrome c oxidase deficiency.
    Diaz F; Thomas CK; Garcia S; Hernandez D; Moraes CT
    Hum Mol Genet; 2005 Sep; 14(18):2737-48. PubMed ID: 16103131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons.
    Tenenbaum A; Motro M; Fisman EZ
    Cardiovasc Diabetol; 2005 Sep; 4():14. PubMed ID: 16168052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.
    Dillon LM; Hida A; Garcia S; Prolla TA; Moraes CT
    PLoS One; 2012; 7(9):e44335. PubMed ID: 22962610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate activation of PPAR drives disturbances in mitochondrial redox bioenergetics and decreases the viability of cells from patients with VLCAD deficiency.
    Lund M; Andersen KG; Heaton R; Hargreaves IP; Gregersen N; Olsen RKJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Jun; 1867(6):166100. PubMed ID: 33549744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy.
    Yao M; Yao D; Yamaguchi M; Chida J; Yao D; Kido H
    Mol Genet Metab; 2011 Nov; 104(3):265-72. PubMed ID: 21816645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical progression of mitochondrial myopathy is associated with the random accumulation of cytochrome c oxidase negative skeletal muscle fibres.
    Chinnery PF; Howel D; Turnbull DM; Johnson MA
    J Neurol Sci; 2003 Jul; 211(1-2):63-6. PubMed ID: 12767499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of bezafibrate in mitochondrial disease.
    Steele H; Gomez-Duran A; Pyle A; Hopton S; Newman J; Stefanetti RJ; Charman SJ; Parikh JD; He L; Viscomi C; Jakovljevic DG; Hollingsworth KG; Robinson AJ; Taylor RW; Bottolo L; Horvath R; Chinnery PF
    EMBO Mol Med; 2020 Mar; 12(3):e11589. PubMed ID: 32107855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function.
    Romanino K; Mazelin L; Albert V; Conjard-Duplany A; Lin S; Bentzinger CF; Handschin C; Puigserver P; Zorzato F; Schaeffer L; Gangloff YG; Rüegg MA
    Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20808-13. PubMed ID: 22143799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.